Chugai Pharmaceutical Co. Ltd. (CHGCY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Chugai Pharmaceutical Co....

    OTC: CHGCY · Real-Time Price · USD
    23.80
    0.64 (2.76%)
    At close: Oct 03, 2025, 3:59 PM
    23.89
    0.40%
    After-hours: Oct 03, 2025, 04:00 PM EDT

    Chugai Pharmaceutical Balance Sheet Statement

    Financials in JPY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Cash & Equivalents
    		 497.09B 423.42B 540.2B 403.96B 393.76B 462.86B 458.67B 331.34B 365.02B 247.69B 222.17B 274.04B 360.31B 230.47B 267.75B 192.52B 187.13B 162.05B
    Short-Term Investments
    		 530.52B 521.13B 456.14B 441.36B 421.9B 301.7B 280.31B 287.42B 299.97B 306.93B 280.94B 271.25B 231.93B 201.35B 204.22B 204.13B 204.1B 181.32B
    Long-Term Investments
    		 n/a n/a 73.07B n/a 67.79B 65.42B 1.25B 4.83B 4.9B 61.52B -279.1B -269.43B -229.62B -198.96B -201.82B -201.45B -201.22B -178.63B
    Other Long-Term Assets
    		 82.16B 142.15B 69.83B 132.17B 65.76B n/a 59.83B 52.44B 58.2B n/a 335.29B 317.9B 273.24B 242.04B 246.49B 232.86B 231.9B 210.27B
    Receivables
    		 316.75B 294.68B 334.26B 326.65B 349.66B 239.67B 318.89B 315.63B 295.33B 360.99B 512.54B 274.66B 268.48B 390.57B 355.08B 292.44B 243.22B 190.71B
    Inventory
    		 235.53B 233.09B 240.07B 273.2B 265.7B 276.68B 273.48B 277.46B 266.4B 278.86B 292.21B 313.01B 218.47B 225.48B 208.84B 201.42B 199.16B 184.66B
    Other Current Assets
    		 39.65B 44.09B 12.36B 35.89B 45.01B 40.94B 13.24B 45.13B 46.11B 32.53B 9.92B 51.6B 47.33B 43.78B 10.47B 23.08B 23.51B 22.24B
    Total Current Assets
    		 1,619.5B 1,516.4B 1,606B 1,481.1B 1,476B 1,321.9B 1,366.4B 1,257B 1,272.8B 1,227B 1,336.5B 1,184.6B 1,126.5B 1,091.6B 1,063.7B 913.6B 857.12B 740.97B
    Property-Plant & Equipment
    		 471.35B 463.61B 441.55B 435.69B 430.23B 426.42B 420.7B 417.83B 405.76B 399.78B 386.65B 373.22B 366.91B 361.13B 352.11B 333.2B 316.87B 298.81B
    Goodwill & Intangibles
    		 33.29B 17.32B 17.87B 20.82B 20.35B 19.56B 19.86B 19.98B 20.69B 19.69B 25.14B 26.34B 25.52B 24.9B 21.97B 24.79B 25.27B 26.02B
    Total Long-Term Assets
    		 658.81B 623.08B 602.33B 588.68B 584.13B 575.91B 566.12B 560.67B 558.77B 544.99B 533.22B 516.25B 499.08B 493.3B 475.03B 439.77B 418.64B 403.66B
    Total Assets
    		 2,278.3B 2,139.5B 2,208.4B 2,069.7B 2,060.2B 1,897.8B 1,932.5B 1,817.6B 1,831.6B 1,772B 1,869.8B 1,700.8B 1,625.6B 1,584.9B 1,538.7B 1,353.4B 1,275.8B 1,144.6B
    Account Payables
    		 78.42B 70.59B 65.35B 76.29B 78.95B 88.72B 112.47B 112.38B 97.8B 166.17B 209.84B 188.22B 93.26B 153.07B 152.27B 138.26B 106.81B 61.57B
    Deferred Revenue
    		 n/a n/a n/a n/a n/a n/a 31M n/a n/a n/a 79M n/a n/a n/a 86M n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Current Liabilities
    		 118.06B 137.84B 169.31B 175.15B 138.5B 150.26B 124.11B 151.75B 200.66B 148.98B 176.06B 180.75B 201.18B 167.44B 140.65B 106.41B 99.1B 82.53B
    Total Current Liabilities
    		 268.28B 208.43B 290.36B 251.45B 290.14B 238.98B 288.22B 264.12B 298.46B 315.15B 423.73B 368.97B 294.44B 320.51B 327.42B 244.67B 205.91B 144.1B
    Long-Term Debt
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 19.73B 23.83B 11.98B 16.92B 13.43B 16.74B 18.37B 18.53B 19.8B 19.9B 21.64B 23.23B 23.82B 23.92B 22.77B 18.05B 17.8B 17.92B
    Total Long-Term Liabilities
    		 24.94B 23.83B 16.52B 16.92B 18.33B 16.74B 18.75B 18.53B 19.8B 19.9B 21.64B 23.23B 23.82B 23.92B 23.25B 18.05B 17.8B 17.92B
    Total Liabilities
    		 293.22B 232.26B 306.87B 268.37B 308.47B 255.72B 306.97B 282.66B 318.27B 335.05B 445.37B 392.19B 318.26B 344.44B 350.68B 262.71B 223.71B 162.02B
    Total Debt
    		 n/a n/a 10.9B n/a 6.58B 6.85B 13.46B 8.43B 7.59B 8.16B 14.11B 9.37B 9.25B 10.09B 16.04B 4.99B 4.73B n/a
    Book Value
    		 1,985.1B 1,907.2B 1,901.5B 1,801.4B 1,751.7B 1,642B 1,625.6B 1,535B 1,513.3B 1,436.9B 1,424.4B 1,308.6B 1,307.3B 1,240.5B 1,188B 1,090.6B 1,052.1B 982.61B
    Book Value Per Share
    		 603.14 579.42 577.51 547.25 532.19 499.00 494.00 466.49 459.94 436.74 432.94 397.76 397.41 377.20 361.24 331.51 319.94 298.86
    Common Stock
    		 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B 73.2B
    Retained Earnings
    		 1,847.5B 1,750.4B 1,746.9B 1,651.3B 1,609.2B 1,497.3B 1,488.7B 1,395.7B 1,383.9B 1,300.7B 1,293.4B 1,187.9B 1,182.6B 1,110.2B 1,054B 954.61B 917.91B 847.19B
    Comprehensive Income
    		 -5.86B 13.52B 11.47B 7.13B -368M 2B -5.71B -3.11B -12.91B -6B -10.97B -21.16B -17.07B -11.41B -7.46B -5.24B -7.02B -5.6B
    Shareholders Equity
    		 1,985.1B 1,907.2B 1,901.5B 1,801.4B 1,751.7B 1,642B 1,625.6B 1,535B 1,513.3B 1,436.9B 1,424.4B 1,308.6B 1,307.3B 1,240.5B 1,188B 1,090.6B 1,052.1B 982.61B
    Total Investments
    		 530.52B 521.13B 529.22B 441.36B 421.9B 367.13B 281.56B 287.42B 299.97B 306.93B 1.84B 1.82B 2.31B 2.38B 2.39B 2.68B 2.88B 2.69B

    Add to Watchlist